ERBB2 and glioblastoma: Given the associations between Posaconazole and ERBB2 (Fig 8), and ERBB2 and glioblastoma (from OMIM), we hypothesized that Posaconazole might be repurposed for glioblastoma, which was further supported by the Translator, shown in Fig 9.